サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487648

アムロジピン市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年

Amlodipine Market (Sensor Type: 2.5 mg, 5 mg, and 10 mg; Application: High Blood Pressure and Heart Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 167 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
アムロジピン市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2034年
出版日: 2024年04月29日
発行: Transparency Market Research
ページ情報: 英文 167 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アムロジピン市場- 調査範囲

TMRの調査レポート「アムロジピンの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るため、過去だけでなく現在の成長動向と機会についても調査しています。2024年を基準年、2034年を予測年として、2018年から2034年までの世界のアムロジピン市場の収益と予測を提供します。また、2024年から2034年までの世界のアムロジピン市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、アムロジピン市場を把握しました。

市場スナップショット
2023年の市場規模 4億1,300万米ドル
2034年の市場価値 6億7,030万米ドル
CAGR 4.4%

当レポートでは、世界のアムロジピン市場の競合情勢について調査しています。世界のアムロジピン市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のアムロジピン市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：タイプ別、2020年～2034年
    • 2.5 mg
    • 5 mg
    • 10 mg
  • 市場魅力度分析：タイプ別

第7章 世界市場分析・予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別、2020年～2034年
    • 高血圧
    • 心臓疾患
  • 市場魅力度分析：用途別

第8章 世界市場分析・予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：流通チャネル別、2020年～2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場魅力度分析：流通チャネル別

第9章 世界市場分析・予測：地域別

  • イントロダクション
  • 主な調査結果/発展
  • 市場金額予測：地域別、2020年～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場競合マトリックス（企業階層別・企業規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Pfizer Inc.
    • Dr. Reddy's Laboratories Limited
    • Cipla Limited
    • Lupin Limited
    • Zydus Pharmaceuticals（USA）Inc.
    • Wockhardt
    • Alkem Laboratories Limited
    • Oxford Pharmaceuticals
    • Mylan N.V.
    • Apotex Inc.
    • Sun Pharma
    • その他
図表

List of Tables

  • Table 01: Global Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 03: Global Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Amlodipine Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Amlodipine Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 07: North America Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 08: North America Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 09: Europe Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 11: Europe Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 12: Europe Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 15: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 16: Asia Pacific Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 17: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 19: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 20: Latin America Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Application, 2020-2034
  • Table 24: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Amlodipine Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Amlodipine Market Revenue (US$ Mn), by Type, 2023
  • Figure 03: Global Amlodipine Market Value Share, by Type, 2023
  • Figure 04: Global Amlodipine Market Revenue (US$ Mn), by Application, 2023
  • Figure 05: Global Amlodipine Market Value Share, by Application, 2023
  • Figure 06: Global Amlodipine Market Revenue (US$ Mn), by Distribution Channel, 2023
  • Figure 07: Global Amlodipine Market Value Share, by Distribution Channel, 2023
  • Figure 08: Global Amlodipine Market Value Share, by Region, 2023
  • Figure 09: Global Amlodipine Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 10: Global Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 11: Global Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 13: Global Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 14: Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 15: Global Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 16: Global Amlodipine Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Amlodipine Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Amlodipine Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 22: North America Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 23: North America Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 24: North America Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 26:North America Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 27: Europe Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 31: Europe Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 32: Europe Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 33: Europe Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 35: Europe Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 36: Asia Pacific Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 40: Asia Pacific Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 41: Asia Pacific Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 42: Asia Pacific Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 44: Asia Pacific Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 45: Latin America Amlodipine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 49: Latin America Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 50: Latin America Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 51: Latin America Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 53: Latin America Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 54: Middle East & Africa Amlodipine Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Amlodipine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Amlodipine Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 58: Middle East & Africa Amlodipine Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 59: Middle East & Africa Amlodipine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 60: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 62: Middle East & Africa Amlodipine Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL86028

Amlodipine Market - Scope of Report

TMR's report on the global amlodipine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global amlodipine market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global amlodipine market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the amlodipine market.

Market Snapshot
Market Value in 2023US$ 413 Mn
Market Value in 2034US$ 670.3 Mn
CAGR4.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global amlodipine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global amlodipine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global amlodipine market.

The report delves into the competitive landscape of the global amlodipine market. Key players operating in the global amlodipine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global amlodipine market profiled in this report.

Key Questions Answered in Global amlodipine Market Report:

  • What is the sales/revenue generated by amlodipine across all regions during the forecast period?
  • What are the opportunities in the global amlodipine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Amlodipine Market - Research Objectives and Research Approach

The comprehensive report on the global amlodipine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global amlodipine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global amlodipine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Amlodipine Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Amlodipine Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Amlodipine Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020-2034
    • 6.3.1. 2.5 mg
    • 6.3.2. 5 mg
    • 6.3.3. 10 mg
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Amlodipine Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020-2034
    • 7.3.1. High Blood Pressure
    • 7.3.2. Heart Diseases
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Amlodipine Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Amlodipine Market Analysis and Forecast, by Region

  • 9.1. Introduction
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Region, 2020-2034
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4. Market Attractiveness Analysis, by Region

10. North America Amlodipine Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Type, 2020-2034
    • 10.3.1. 2.5 mg
    • 10.3.2. 5 mg
    • 10.3.3. 10 mg
  • 10.4. Market Value Forecast, by Application, 2020-2034
    • 10.4.1. High Blood Pressure
    • 10.4.2. Heart Diseases
  • 10.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.5.1. Hospital Pharmacies
    • 10.5.2. Retail Pharmacies
    • 10.5.3. Online Pharmacies
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Type
    • 10.7.2. By Application
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Amlodipine Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Type, 2020-2034
    • 11.3.1. 2.5 mg
    • 11.3.2. 5 mg
    • 11.3.3. 10 mg
  • 11.4. Market Value Forecast, by Application, 2020-2034
    • 11.4.1. High Blood Pressure
    • 11.4.2. Heart Diseases
  • 11.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Application
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Amlodipine Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Type, 2020-2034
    • 12.3.1. 2.5 mg
    • 12.3.2. 5 mg
    • 12.3.3. 10 mg
  • 12.4. Market Value Forecast, by Application, 2020-2034
    • 12.4.1. High Blood Pressure
    • 12.4.2. Heart Diseases
  • 12.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Application
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Amlodipine Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Type, 2020-2034
    • 13.3.1. 2.5 mg
    • 13.3.2. 5 mg
    • 13.3.3. 10 mg
  • 13.4. Market Value Forecast, by Application, 2020-2034
    • 13.4.1. High Blood Pressure
    • 13.4.2. Heart Diseases
  • 13.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Application
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Amlodipine Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Type, 2020-2034
    • 14.3.1. 2.5 mg
    • 14.3.2. 5 mg
    • 14.3.3. 10 mg
  • 14.4. Market Value Forecast, by Application, 2020-2034
    • 14.4.1. High Blood Pressure
    • 14.4.2. Heart Diseases
  • 14.5. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Application
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. Pfizer Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Dr. Reddy's Laboratories Limited
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Cipla Limited
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Lupin Limited
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Zydus Pharmaceuticals (USA) Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Wockhardt
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Alkem Laboratories Limited
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Oxford Pharmaceuticals
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Mylan N.V.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Apotex Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Sun Pharma
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. Others
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview